Fishman Mark 4
4 · Beam Therapeutics Inc. · Filed Jun 14, 2021
Insider Transaction Report
Form 4
Fishman Mark
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-10+6,877→ 6,877 totalExercise: $87.91Exp: 2031-06-10→ Common Stock (6,877 underlying)
Footnotes (1)
- [F1]The option vests in full on the first anniversary of the date of grant, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date.